Company Filing History:
Years Active: 1996
Sure, I can help you with that. Here is the article about inventor Dennis M Katkocin:
Title: Innovator Spotlight: Dennis M Katkocin - Pioneer in Thermostable Cyclodextrin Glycosyl Transferase
Introduction:
Dennis M Katkocin, a respected innovator in the field of biotechnology, hails from New Fairfield, CT, in the United States. With a keen eye for groundbreaking solutions, Dennis has made significant contributions to the industry with his patented inventions.
Latest Patents:
Dennis M Katkocin holds a notable patent titled "Thermostable Cyclodextrin Glycosyl Transferase and Processes Using It." This patent introduces novel cyclodextrin glycosyl transferases (CGTase) that exhibit exceptional thermostability compared to known CGTases. These enzymes, produced through anaerobic cultivation of specific strains, have a temperature optimum of around 95°C. They are instrumental in starch liquefaction and the production of dextrose, ethanol, and cyclodextrin at high temperatures, showcasing Dennis's innovative approach to enzymatic processes.
Career Highlights:
Dennis M Katkocin is associated with Novo Nordisk A/S, a prominent biopharmaceutical company known for its groundbreaking solutions in healthcare. Within the company, Dennis has led projects focusing on enhancing enzymatic processes, particularly in the realm of starch conversion and product synthesis. His expertise and dedication have significantly impacted the field of biotechnology.
Collaborations:
Throughout his career, Dennis M Katkocin has collaborated with accomplished professionals in the industry, including Robert L Starnes and Philip C Trackman. Together, they have worked on research projects, shared insights, and pushed boundaries to innovate and develop cutting-edge technologies.
Conclusion:
In conclusion, Dennis M Katkocin stands out as a visionary inventor who has revolutionized the field of biotechnology with his inventive solutions. His work on thermostable cyclodextrin glycosyl transferases has paved the way for advancements in enzymatic processes and product synthesis, demonstrating his commitment to driving innovation forward in the industry.